https://orcid.org/0000-0002-1331-942X
References
- Prince M, Comas-Herrera A, Knapp M, et al. World Alzheimer Report 2016: improving healthcare for people living with dementia. London: Alzheimer’s Disease International; 2016.
- Alzheimer’s Disease International. Policy brief for heads of government: the global impact of Dementia 2013–2050. London: Alzheimer's Disease International; 2013.
- International Alzheimer’s Disease Research Portfolio. [cited 2019 Dec 25]. Available from: https://iadrp.nia.nih.gov/.
- Cummings JL, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6:37.
- Cummings J, Lee G, Mortsdorf T, et al. Alzheimer’s disease drug development pipeline: 2017. Alzheimers Dement (N Y). 2017;3:367–384.
- Cummings J, Lee G, Ritter A, et al. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018;4:195–214.
- Cummings J, Lee G, Ritter A, et al. Alzheimer’s disease drug development pipeline: 2019. Alzheimers Dement (N Y). 2019;5:272–293.
- Woods B, Aguirre E, Spector AE, et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;2:CD005562.
- Livingston G, Barber J, Rapaport P, et al. Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ. 2013;347:f6276.
- Knapp M, Wong G. Economics and mental health: the current scenario. World Psychiatry. 2020;19:3–14.
- Shah H, Albanese E, Duggan C, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016;15:1285–1294.
- Pickett J, Bird C, Ballard C, et al. A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. Int J Geriatr Psychiatry. 2018;33:900–906.
- Yoshida S. Approaches, tools and methods used for setting priorities in health research in the 21(st) century. J Glob Health. 2016;6:010507.
- Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455–532.
- Banerjee S, Smith, SC, Lamping DL, et al. Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia. J Neurol Neurosurg Psychiatry. 2006;77:146–148.
- Ballard C, Corbett A, Orrell M, et al. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial. PLoS Med. 2018;15:e1002500.
- Leicht H, Konig HH, Stuhldreher N, et al. Predictors of costs in dementia in a longitudinal perspective. PLoS One. 2013;8:e70018.
- Joling KJ, Schope J, van Hout HP, et al. Predictors of societal costs in dementia patients and their informal caregivers: a two-year prospective cohort study. Am J Geriatr Psychiatry. 2015;23:1193–1203.
- Alzheimer’s Research UK. Thinking differently: preparing today to implement future dementia treatments. Cambridge: Alzheimer's Research UK. 2018.
- Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–165.